Huhn, G. D., Shamblaw, D. J., Baril, J., Hsue, P. Y., Mills, B. L., Nguyen-Cleary, T., . . . Das, M. (2019). Atherosclerotic Cardiovascular Disease Risk Profile of Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate. Open Forum Infect Dis.
Styl ChicagoHuhn, Gregory D., David J. Shamblaw, Jean-Guy Baril, Priscilla Y. Hsue, Brittany L. Mills, Thai Nguyen-Cleary, Scott McCallister, a Moupali Das. "Atherosclerotic Cardiovascular Disease Risk Profile of Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate." Open Forum Infect Dis 2019.
Citace podle MLAHuhn, Gregory D., et al. "Atherosclerotic Cardiovascular Disease Risk Profile of Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate." Open Forum Infect Dis 2019.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..